Home > Healthcare > Medical Devices > Diagnostic Devices > allergy diagnostics market
Get a free sample of Allergy Diagnostics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Allergy Diagnostics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Significant increase in number of patients suffering from allergic diseases attributable to growing environmental pollution levels, unhealthy habits such as smoking, and rise in occupational & seasonal allergy incidences among others will primarily drive the market trends. As per the Asthma and Allergy Foundation of America, allergic rhinitis, a type of respiratory allergy, is among the major health problems globally that causes itching, nasal obstruction, fatigue, and other complications. This can cause due to various seasonal or inflammatory disorders that needs proper diagnosis and treatment facilities.
Increasing prevalence of such ailments fuel the demand for allergy diagnostic devices significantly. This rising diseased population is resulting in high adoption of advanced allergy diagnostic devices that enable a doctor to examine the severe allergic conditions more effectively with highest precision.
The in vivo tests segment was around USD 2.9 billion in 2022 owing to awareness regarding its benefits like patch test, skin prick tests, and challenge tests.
Global market for allergy diagnostics was around USD 5.4 billion in 2022 and will reach over USD 15.2 billion in 2032.
Danaher Corporation, Thermo Fisher Scientific Inc., Omega Diagnostics Group PLC, Siemens Healthcare Diagnostics, Inc., and Stallergenes SA are a few of the leading companies in the allergy diagnostics market.
Diagnostic laboratories segment will record 11.2% CAGR between 2023 to 2032 due to a rise in target population suffering from different allergy disorders.